喘中的失脂症:可治疗的特征,还是只是一种常见的并发症?
Ke Deng1,2,3, Ji Wang1,2,3, Brian G Oliver4,5
1Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Chinese medical journal
|November 14, 2025
概括
带有失脂症的喘是一种新兴的表型. 了解其特征和机制是开发针对这种常见并发性疾病的新治疗方法的关键.
科学领域:
- 肺病学和代谢医学
背景情况:
- 喘呈现多种现象,包括与肥胖相关的和过敏性喘.
- 脱脂症是与喘越来越常见的并发症,这表明了明显的喘表型.
- 与其他可治疗的特征相比,目前关于喘与失脂症的研究是有限的.
研究的目的:
- 为了提供一个全面的喘与失脂血症的综述.
- 巩固现有的临床,炎症和机械方面的知识.
- 为了确定管理这种情况的潜在治疗目标.
主要方法:
- 关于喘和失脂症的现有研究的文献综述.
- 临床和炎症特征的分析.
- 探索潜在的病理生理机制.
主要成果:
- 喘与失脂症症构成一个重大且研究不足的临床挑战.
- 确定特定的特征和机制对于有针对性的管理至关重要.
- 本综述综合了当前的理解,以指导未来的研究.
结论:
- 喘与失脂症需要进一步调查,以建立有效的管理策略.
- 失脂症是喘新型治疗干预措施的潜在目标.
- 为了改善患者的治疗结果,全面的了解是必不可少的.
更多相关视频
相关概念视频
Atherosclerosis III: Management
307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K


